from 01.01.2013 until now
Kazan', Kazan, Russian Federation
student from 01.01.2022 until now
Zvenigovo, Yoshkar-Ola, Russian Federation
UDC 338.2
UDC 33
CSCSTI 06.03
CSCSTI 06.81
This study examines the theoretical and practical aspects of developing an enterprise's strategy in monopolistic competition. Using a pharmacy as an example, the following elements of monopolistic competition are examined: institutional constraints, the impact of digital technology development, the pharmacy's purpose and mission, the consistent availability of product assortment, the epidemiological situation, the pharmacy's location, pharmaceutical import substitution processes, and government influence. A PEST and SWOT analysis were conducted to determine the pharmacy's potential for developing a winning strategy in monopolistic competition. The proposed key areas of the enterprise's strategy include developing a loyalty program, switching suppliers and establishing long-term relationships with them, and expanding and deepening the range of pharmaceutical products. At the pharmacy level, the old strategy (passive-competitive strategy) and the new strategy (active-competitive strategy) are characterized. The analysis demonstrates a fundamental shift in the pharmacy's competitive position – from passively following the market to actively developing competitive advantages in monopolistic competition. It is also noted that the adaptation of economic entities to changes in the market environment is becoming a key factor in ensuring the stability of the industry and the national economy as a whole.
enterprise strategy, monopolistic competition, PEST analysis of a pharmacy, SWOT analysis of a pharmacy, passive-competitive strategy, active-competitive strategy
1. Ekonomicheskaya teoriya nesovershennoy konkurencii Per. s angl. / Dzh. Robinson; Vstup. st. i obsch. red. I. M. Osadchey. Moskva: Progress, 1986.
2. Chemberlin E.H. Teoriya monopolisticheskoy konkurencii. Reorientaciya teorii stoimosti. Per. s angl. M.: Ekonomika, 1996. 351 s.
3. Porter M. Konkurenciya. M.: Vil'yams, 2018. 608 s.
4. Paul R. Krugman. Increasing returns, monopolistic competition, and international trade. Journal of International Economics,Vol. 9, Issue 4, 1979, Pages 469-479ISSN 0022-1996, https://doi.org/10.1016/0022-1996(79)90017-(https://www.sciencedirect.com/science/article/pii/0022199679900175). (data obrascheniya: 11.01.2026).
5. Mathieu Parenti, Philip Ushchev, Jacques-François Thisse. Toward a theory of monopolistic competition. Journal of Economic Theory, Vol. 167, 2017, Pages 86-115, https://doi.org/10.1016/j.jet.2016.10.005. (https://www.sciencedirect.com/science/article/pii/S0022053116300916. (data obrascheniya: 11.01.2026).
6. Kristian Behrens & Giordano Mion & Yasusada Murata & Jens Suedekum, 2020. "Quantifying the Gap Between Equilibrium and Optimum under Monopolistic Competition," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 135(4), pages 2299-2360. DOI: https://doi.org/10.1093/qje/qjaa017
7. Porter M. Konkurentnaya strategiya. Metodika analiza otrasley i konkurentov. – M.: Al'pina Pablisher, 2018. 456 s.
8. Kleyner G.B. Predpriyatie v nestabil'noy srede: riski, strategii, bezopasnost' / G.B. Kleyner, V.L. Tambovcev, R.M. Kachalov. - M.: Ekonomika, 2020. 288 s.
9. Kobylko A.A. Strategiya predpriyatiya vo vremeni i prostranstve: monografiya. M.: FGBUN NIC «Nauka» RAN, 2025. 168 s. DOI: https://doi.org/10.52929/9785605453611; EDN: https://elibrary.ru/PDKAEM
10. Tihonova M.V., Mitina A.S. Aktual'nye vyzovy rossiyskoy farmacevticheskoy otrasli i puti razvitiya // Ekonomicheskie nauki. 2025. № 249. S. 203-210. DOI:https://doi.org/10.14451/1.249.203 EDN: https://elibrary.ru/EXCSNJ
11. Komarov P.A., Kramlih O.Yu., Tumbulyan I.G. Tendencii razvitiya rossiyskogo farmacevticheskogo rynka v sovremennyh usloviyah. // Vestnik Altayskoy Akademii ekonomiki i prava. 2025. № 1. S. 67-73. DOI: https://doi.org/10.17513/vaael.3961; EDN: https://elibrary.ru/GTYEJS
12. Nezhnikova E.V., Maksimchuk M.V. Farmacevticheskaya otrasl' v RF: problemy i perspektivy razvitiya // Vestnik Rossiyskogo universiteta druzhby narodov. Seriya: Ekonomika. 2019. T. 27. № 1. S. 102—112. DOI:https://doi.org/10.22363/2313-2329-2019-27-1-102-112. EDN: https://elibrary.ru/TFHWQO
13. Chemberlin E.H. Teoriya monopolisticheskoy konkurencii. Reorientaciya teorii stoimosti. Per. s angl. M.: Ekonomika, 1996. 351 s
14. Fisher S., Dornbush R., Shmalenzi R. Ekonomika. Per. s angl. M.: Delo LTD, 1993. 864 c.
15. Kobylko A.A. Strategiya predpriyatiya vo vremeni i prostranstve: monografiya. M.: FGBUN NIC «Nauka» RAN, 2025. 168 s. DOI: https://doi.org/10.52929/9785605453611; EDN: https://elibrary.ru/PDKAEM
16. Kalinovskaya E.N. Indikatory farmacevticheskogo rynka // Farmacevticheskiy vestnik. 2025. №28-30 91187-1189. https://pharmvestnik.ru/articles/indikatory-farmacevticheskogo-rynka-2.html. (data obrascheniya: 11.01.2026).
17. Kolganova V. Apteki podvel nasmork // Gazeta «Kommersant'». №155. 27.08.2025. https://www.kommersant.ru/doc/7990345. (data obrascheniya: 11.01.2026).
18. Burganov R. A. Ekonomicheskaya koncentraciya: suschnost' i osobennosti proyavleniya v konkurentnoy srede. Kazan': Tan-Zarya, 2003. 279 s. EDN: https://elibrary.ru/QQCXMZ
